Search

Search Constraints

You searched for: Author/Creator Melcarne, L

Search Results

1. DOP40 Comorbidities and epidemiological risk factor but not immunosuppressive therapies increase the risk of COVID-19 in Inflammatory Bowel Disease (IBD): An ENEIDA-based, case-control study. (27th May 2021)

2. OP26 Impact of telemonitoring on the management of Inflammatory Bowel Disease in Spain: a multicenter TECCU clinical trial. (30th January 2023)

3. P319 Impact of biological agents on postoperative complications in inflammatory bowel disease: a multicentre study of GETECCU. (27th May 2021)

4. P335 Impact of cancer therapy on the course of Inflammatory Bowel Disease (ONCOEII study of GETECCU). (30th January 2023)

5. P338 effectiveness and safety of biological therapies in elderly inflammatory bowel diseases patients results from a multi center study of Geteccu. (27th May 2021)

6. P410 Safety of biological drugs for inflammatory bowel disease in elderly patients. (21st January 2022)

7. P481 Profile of elderly patients in which biological drugs are used for the treatment of inflammatory bowel disease. (21st January 2022)

8. P523 Effectiveness of biological treatments for inflammatory bowel disease in the elderly patients. (21st January 2022)

10. P605 Development and validation of an objective disability index for Inflammatory Bowel Disease patients (ODIBD). (27th May 2021)